Omega Diagnostics Group PLC announced that Chris Lea will be stepping down as a Director with immediate effect. Chris has been instrumental in selling the Alva site and subsequent sale of the CD4 Business along with a restructuring of Omega,based in Ely, Cambridgeshire. The restructuring and disposals were key in refocusing the Company on food intolerance testing and ensuring it has sufficient resources to drive Omega forward.

Chris is based in Scotland and his stepping down is in line with the company strategy to focus more of its resources in and around the company's headquarters in Ely, Cambridge.